Table 3.
Socioeconomic, clinical, and health utilization characteristics of the study population for persons with and without MS (year 2015)
| Characteristic | Measure | MS patients | no MS | Total | p-value |
|---|---|---|---|---|---|
| Age (years) | n (%) | 1,606 (0.2) | 942,033 (99.8) | 943,639 (100) | |
| mean (median) | 45.5 (46) | 51.8 (51) | 51.8 (51) | <0.001 | |
| Age group: 19–25 | n (%) | 72 (4.5) | 89,567 (9.5) | 89,639 (9.5) | <0.001 |
| 26–30 | n (%) | 117 (7.3) | 64,042 (6.8) | 64,159 (6.8) | |
| 31–35 | n (%) | 197 (12.3) | 74,756 (7.9) | 74,953 (7.9) | |
| 36–40 | n (%) | 203 (12.6) | 76,922 (8.2) | 77,125 (8.2) | |
| 41–45 | n (%) | 213 (13.3) | 76,807 (8.2) | 77,020 (8.2) | |
| 46–50 | n (%) | 263 (16.4) | 81,874 (8.7) | 82,137 (8.7) | |
| 51–55 | n (%) | 208 (13.0) | 80,971 (8.6) | 81,179 (8.6) | |
| 56–60 | n (%) | 136 (8.5) | 73,440 (7.8) | 73,576 (7.8) | |
| 61–65 | n (%) | 99 (6.2) | 68,397 (7.3) | 68,496 (7.3) | |
| 66–70 | n (%) | 57 (3.5) | 67,796 (7.2) | 67,853 (7.2) | |
| 71–75 | n (%) | 25 (1.6) | 60,260 (6.4) | 60,285 (6.4) | |
| 76–80 | n (%) | 14 (0.9) | 48,479 (5.1) | 48,493 (5.1) | |
| 81–85 | n (%) | 1 (0.1) | 39,501 (4.2) | 39,502 (4.2) | |
| 86–90 | n (%) | 1 (0.1) | 25,520 (2.7) | 25,521 (2.7) | |
| 91 –… | n (%) | 0 (0.0) | 13,701 (1.5) | 13,701 (1.5) | |
| Female | n (%) | 1,170 (72.9) | 494,508 (52.5) | 495,678 (52.5) | <0.001 |
| Deductible (CHF) | Mean (median) | 401 (300) | 879 (300) | 878 (300) | <0.001 |
| Low deductiblea | n (%) | 1,519 (94.6) | 639,544 (67.9) | 641,063 (67.9) | <0.001 |
| Managed care plan | n (%) | 777 (48.4) | 556,543 (59.1) | 557,320 (59.1) | <0.001 |
| Accident coverage | n (%) | 808 (50.3) | 499,799 (53.1) | 500,607 (53.1) | 0.030 |
| Suppl inpatient insurance coverage “yes” | n (%) | 245 (15.3) | 171,417 (18.2) | 171,662 (18.2) | 0.003 |
| No of PCGs | Mean (median) | 2 (2) | 1.3 (1) | 1.3 (1) | <0.001 |
| No of different ATC | Mean (median) | 10.8 (9) | 6.7 (4) | 6.7 (4) | <0.001 |
| Deceased | n (%) | 5 (0.3) | 12,265 (1.3) | 12,270 (1.3) | <0.001 |
| Cost of MS medication | Mean (median) | 19,609 (20,326) | 0 (0) | 33 (0) | <0.001 |
| Cost of total medication | Mean (median) | 21,023 (20,930) | 1,048 (205) | 1,082 (206) | <0.001 |
| Outpatient cost | Mean (median) | 27,459 (26,509) | 3,452 (1,372) | 3,493 (1,378) | <0.001 |
| Inpatient cost | Mean (median) | 1,486 (0) | 1,513 (0) | 1,513 (0) | 0.050 |
| Total cost | Mean (median) | 28,945 (27,269) | 4,965 (1,466) | 5,006 (1,472) | <0.001 |
| No of GP visits | Mean (median) | 5.4 (4) | 3.7 (2) | 3.7 (2) | <0.001 |
| No of specialist visits | Mean (median) | 7.6 (5) | 3.4 (1) | 3.4 (1) | <0.001 |
| No of hospital outpatient visits | Mean (median) | 6.8 (3) | 2.3 (0) | 2.3 (0) | <0.001 |
| Inpatient length of stay | Mean (median) | 1.4 (0) | 1.6 (0) | 1.6 (0) | 0.332 |
| No of hospitalization episodes | Mean (median) | 0.2 (0) | 0.2 (0) | 0.2 (0) | 0.416 |
Note:
a
≤500 CHF per year.
Abbreviations: CHF, Swiss Francs; GP, general practitioner; MS, multiple sclerosis; PCGs, pharmaceutical cost groups; ATC, Anatomical Therapeutic Chemical; Suppl, supplementary.